Clinical Trials Logo

Anesthesia, Spinal clinical trials

View clinical trials related to Anesthesia, Spinal.

Filter by:

NCT ID: NCT02980926 Completed - Pain Management Clinical Trials

Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty

Start date: December 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if a shorter-acting spinal anesthetic called mepivacaine has advantages over a longer-acting medication called bupivacaine.

NCT ID: NCT02961842 Completed - Cesarean Section Clinical Trials

Combined Colloid Preload And Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery

Start date: November 20, 2016
Phase: N/A
Study type: Interventional

The study will compare one technique of fluid administration (combined colloid preload and crystalloid colaod) with another one (crystalloid coload) during elective cesarean delivery performed under spinal anesthesia.

NCT ID: NCT02958215 Completed - Anesthesia, Spinal Clinical Trials

Phenylephrine and Hypotension During Spinal Anesthesia for Cesarean Section

Start date: June 2016
Phase: Phase 2
Study type: Interventional

Pregnant women with a positive preoperative Supine stress test were found to be a subgroup at increased risk of symptomatic hypotension after spinal anesthesia

NCT ID: NCT02833376 Completed - Anesthesia, Spinal Clinical Trials

Alcohol 70% Versus Chlorhexidine 0.5% in the Spinal Anesthesia Skin Antissepsis

Start date: May 30, 2016
Phase: N/A
Study type: Interventional

Context: The neuraxial blocks, spinal anesthesia and epidural anesthesia are among the most frequently performed procedures worldwide, and despite the advancements of medical equipment, remain dependent on experience and practice of the anesthesiologists. Although antisepsis takes part of the daily routine, there are still no solid scientific evidence of the most appropriate antiseptic for these procedures. Objective: To compare the 70% alcohol and 0.5% chlorhexidine alcohol solution in skin antisepsis for the neuraxial blocks. Methods: This is a clinical trial, a prospective, randomized study. There will be selected, consecutively, 70 patients candidates for neuraxial blocks. Patients will be randomly assigned to group A (n = 35), in which the antisepsis will be performed with alcohol 70%, and to group B (n = 35), in which the antiseptic will be performed with the 0.5% chlorhexidine in alcoholic solution. Samples will be collected with swabs in an area of 25 cm² for bacterial cultures three times: in pre-antisepsis moments, in the second minute after antisepsis, and immediately after the puncture. The number of colonies forming units per square centimeter (CFU / cm²) will be counted. The data will be analyzed statistically.

NCT ID: NCT02813382 Completed - Hernia, Inguinal Clinical Trials

Spinal Anesthesia for Outpatient Abdominal Wall Surgery: Comparison of Bupivacaine, 2-chloroprocaine and Prilocaine

spinal
Start date: August 2015
Phase: N/A
Study type: Observational

Considering fast-track principles, an ideal spinal anesthetic should have minimal complications and above all fast recovery so reducing in-hospital stay. Between 1/8/2015 and 1/1/2016, a total of 101 patients attending the surgeon's practice with an umbilical or unilateral inguinal hernia and no contra-indications for surgery were included in this study. Patients were given 10.5mg bupivacaine (B-group), 40mg hyperbaric 2-chloroprocaïne (C-group) or 60mg prilocaïne (P-group), each with added sufentanil (2µg). Motor block was assessed using the Bromage scale. Sensory block was measured by determining the peak level dermatome. Intraoperative hemodynamic parameters were listed. Resolution of sensory and motor block, time to void and home readiness were defined as clinical endpoints.

NCT ID: NCT02737813 Completed - Hypotension Clinical Trials

Cardiac Output Changes During Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Cesarean Section

Start date: March 29, 2016
Phase: Phase 4
Study type: Interventional

Spinal block leads to the reduction of systemic vascular resistance (SVR) which may effect the cardiac output. Ngan Kee et al. has showed that spina block with 0.5% hyperbaric bupivacaine for Cesarean section combined with intravenous infusion norepinephrine had higher cardiac output than those who received phenylephrine

NCT ID: NCT02365857 Completed - Anesthesia, Spinal Clinical Trials

Intrathecal Dexmedetomidine With Bupivacaine for Spinal Anesthesia in Cesarean Section

Start date: December 2014
Phase: Phase 4
Study type: Interventional

A Randomized, Controlled, Double blind study aiming to evaluate the analgesic potentials and side effect profile of different dose levels of Dexmedetomidine added to subarachnoid bupivacaine in full-term pregnant women undergoing elective cesarean section using spinal anesthesia. The investigators ultimate goal is to find out the least effective dose which will be associated with minimal or no side effects. The primary outcome will be the time to two sensory block segment regression.

NCT ID: NCT00991627 Completed - Pregnancy Clinical Trials

Different Approaches to Maternal Hypotension During Cesarean Section

Start date: September 2009
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare two different therapeutic approaches to blood pressure reduction: pharmacological vs. non-pharmacological. The setting is that of patients undergoing scheduled Cesarean section under spinal anesthesia and suffering from aorta-caval compression syndrome, which causes a sudden drop in blood pressure.

NCT ID: NCT00921102 Completed - Cesarean Section Clinical Trials

Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section

Start date: May 2007
Phase: Phase 4
Study type: Interventional

The aim of this study is to assess the efficacy of atropine in preventing nausea and vomiting after spinal anesthesia with local anesthetic and morphine for elective Caesarean section. Patients enrolling in the study will be assigned to one of three groups. One will receive a small dose of intrathecal atropine; another will receive small-dose intravenous atropine; the third group will receive placebo.

NCT ID: NCT00358280 Completed - Anesthesia,Spinal Clinical Trials

Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery

Start date: April 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy, duration of motor block until return to normal function in the non-operated leg after the start of injection, of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml when used for spinal anaesthesia in patients undergoing unilateral lower limb surgery.